Who are Paragonix Technologies's investors?

Paragonix Technologies's investors include Signet Healthcare Partners.

How much funding has Paragonix Technologies raised?

Paragonix Technologies has disclosed $23.7M raised across 1 round.

Where is Paragonix Technologies headquartered?

Paragonix Technologies is headquartered in Cambridge, US.

Paragonix Technologies

Cambridge, US · Delaware corporation · 1 known investors

Paragonix Technologies develops, manufactures, and services organ preservation devices that combine cooling techniques with digital tracking and monitoring for clinicians managing donor organs during transplantation. It also maintains the GUARDIAN clinical registries, a database of organ preservation and post-transplant outcome data, serving the organ transplant industry.

Hardware Healthtech Medical Devices

Founders & leadership

DeWitt DavenportNamed on SEC filing

John CammettNamed on SEC filing

Carl RickenbaughNamed on SEC filing

Alexander ArrowNamed on SEC filing

John McDermottNamed on SEC filing

Lisa AndersonNamed on SEC filing

Investors · 1

Signet Healthcare PartnersNew York · $10M – $50M

Reported raises · per SEC filings

Form D private placements

$23.7M disclosed across 1 round · 2023

▶$23.7MraisedMar 2023 · 11 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

DeWitt DavenportDirector
John CammettDirector
Carl RickenbaughDirector
Alexander ArrowDirector
John McDermottDirector
Lisa AndersonExecutive Officer, Director

Offering amount: $23.7M
Amount sold: $23.7M
First sale: Mar 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Organ Recovery55 shared keywordsOrgan Recovery Systems develops organ preservation products and services, including machine perfusion technology for donor kidneys, for transplant programs and transplant professionals. The company supports over 400 transplant programs across 49 countries and also provides clinical and technical support services.

OrganOx27 shared keywordsOrganOx develops the metra platform, a device that extends organ preservation time for liver transplants by maintaining continuous perfusion with oxygenated blood-based solutions, enabling surgeons to better assess organ viability and make more informed transplant decisions.

Companies competing with Paragonix Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Paragonix Technologies do?: Paragonix Technologies develops, manufactures, and services organ preservation devices that combine cooling techniques with digital tracking and monitoring for clinicians managing donor organs during transplantation. It also maintains the GUARDIAN clinical registries, a database of organ preservation and post-transplant outcome data, serving the organ transplant industry.
Who are Paragonix Technologies's investors?: Paragonix Technologies's investors include Signet Healthcare Partners.
How much funding has Paragonix Technologies raised?: Paragonix Technologies has disclosed $23.7M raised across 1 round.
Where is Paragonix Technologies headquartered?: Paragonix Technologies is headquartered in Cambridge, US.